期刊文献+

埋藏式心脏转复除颤器植入术中除颤阈值测试的管理 被引量:1

Management of defibrillation threshold test in the implantation of implantable cardioverter defibrillator
下载PDF
导出
摘要 目的探讨埋藏式心脏转复除颤器(ICD)植入术中除颤阈值(DFT)测试过程中的监护与管理要点,降低测试过程中的并发症发生率。方法回顾性分析50例植入ICD患者术中DFT测试与管理的过程,观察在规范化监护和管理下并发症的发生率。结果 50例患者植入手术过程顺利。1例患者在测试中首次除颤未成功,第2次予最大能量除颤成功;1例在行DFT测试后出现持续低血压和低血氧状态,通过及时应用升压药和增大给氧流量后恢复;1例患者诱发室颤未成功,放弃DFT测试,给予经验性能量设置。术后所有患者生命体征平稳,无手术相关重大并发症发生。结论 ICD除颤阈值测试的过程中,有出现持续低血压、低血氧和除颤阈值偏高等情况的可能,全面、有效的监护管理能显著降低DFT测试中的风险。 Objective To explore the guardianship and management points of defibrillation threshold test(DFT) in the implantation of implantable cardioverter defibrillator (ICD). Methods Test and management procedures of DFT in 50 patients with ICD implantation were analyzed retro- spectively. Incidence rate of complications was observed under the standardized guardianship and management. Results All the patients had successful operations. One patient failed in the first de- fibrillation, and then had successful defibrillation with a maximum energy in second time. One patient had persistent hypotension and hypoxemia after DFT, which were corrected after application of presmr agent and increasing of oxygen flow. One patient received empirical energy setting instead of DET because of ventricular fibrillation. After the operation, all the patients'vital signs were stable, and no one had severe operation- related complications, Conclusion Persistent hypotension, hypoxemia and high defibrillation threshold may occur in process of DFT, and comprehensive and ef- fective management and guardianship can significantly reduce the risks in DFT.
出处 《实用临床医药杂志》 CAS 2013年第2期45-47,共3页 Journal of Clinical Medicine in Practice
关键词 埋藏式心脏转复除颤器 除颤阈值测试 管理 implantable cardioverter defibrillator defibrillation threshold test management
  • 相关文献

参考文献16

  • 1Moss A,Hall W,Cannom D. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia[J].New England Journal of Medicine,1996.1933.
  • 2Kuck K H,Cappato R,Siebels J. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest:The cardiac arrest study Hamburg (CASH)[J].Circulation,2000.748.
  • 3The Antiarrhythmic versus Implantable Defibrillators (AVID) Investigators. Acomparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias[J].New England Journal of Medicine,1997.1576.
  • 4Conolly S J,Gent M,Roberts R S. Canadian implantable defibrillator study (CIDS).A randomized trial of implantable cardioverter defibrillator against amiodarone[J].Circulation,2000.1297.
  • 5Stein K M,D evereux R B,Hahn R T. Effec to f transtho racic shocks on leftventricular function[J].Resuscitation,2005,(03):309.
  • 6Steinbeck G,Dorwarth U,Mattke S. Hemodynamic deterioration during ICD implant predictors of high risk patients[J].American Heart Journal,1994,(42):1064.
  • 7Zima E,Gergely M,Soós P. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length[J].Journal of Cardiovascular Electrophysiology,2006,(04):377.
  • 8Sharma A D,Fain E,O'Neill P G. Shock on T versus direct current voltage for induction of ventricular fibrillation:a randomized prospective comparison[J].Pacing and Clinical Electrophysiology,2004,(01):89.
  • 9Mazer C D,Greene M B,Misale P S. Transcutaneous T wave shock:a universal method for ventricular fibrillation induction[J].Pacing and Clinical Electrophysiology,1997,(12):2930.
  • 10Strickberger S A,Daoud E G,David son T. Probability of successful defibrillation at multiples of the defibrillation energy requirernent in patients with an implantable defibrillator[J].Circulation,1997.1217.

二级参考文献16

  • 1Birnie D,Tung S,Simpson C,et al.Complications associated with defibrillation threshold testing:the Canadian experience.Heart Rhythm,2008,5:387-390.
  • 2Brignole M,Raciti G,Bongiorni MG,et al.Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice:a nation-wide survey.Europace,2007,9:540-543.
  • 3Swerdlow CD,Russo AM,Degroot PJ.The Dilemma of ICD Implant Testing.Pacing Clin Electrophysiol,2007,30:675-700.
  • 4Gold MR,Higgins S,Klein R,et al.Efficacy and temporal stability of reduced safety margins for ventricular defibrillation:primary results from the Low Energy Safety Study (LESS).Circulation,2002,105:2043-2048.
  • 5Pires LA,Johnson KM.Intraoperative testing of the implantable cardioverter-defibrillator:how much is enough? J Cardiovasc Electrophysiol,2006,17:140-145.
  • 6Blatt JA,Poole JE,Johnson GW,et al.No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).J Am Coll Cardiol,2008,52:551-556.
  • 7Bianchi S,Ricci RP,Biscione F,et al.Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing:2-year follow-up.Pacing Clin Electrophysiol,2009,32:573-578.
  • 8Strickberger SA,Klein GJ.Is defibrillation testing required for defibrillator implantation.J Am Coll Cardiol,2004,44:88-91.
  • 9Neuzner J.Is DFT testing still mandatory.Herz,2005,30:601-606.
  • 10Viskin S,Rosso R.The top 10 reasons to avoid defibrillation threshold testing during ICD implantation.Heart Rhythm,2008,5:391-393.

共引文献2

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部